Developer docs
API playgroundTry for free, no card

Search company profiles

National Institute for Research in Tuberculosis

Full company profile

uuid0026sri

Namestring
National Institute for Research in Tuberculosis
Legal namestring
ICMR National Institute for Research in Tuberculosis
Websiteurl
nirt.res.in
Company typeenum
Private
Founded yearint
1956
Descriptiontext

The National Institute for Research in Tuberculosis (ICMR-NIRT) is a Government of India research institute established in 1956 and headquartered in Chetpet, Chennai, under the Indian Council of Medical Research (ICMR) within the Ministry of Health and Family Welfare. It functions as the National Reference Laboratory for Tuberculosis and operates 16 specialized divisions covering bacteriology, biochemistry, clinical pharmacology, clinical research, epidemiology, health economics, immunology, virology and biotechnology, statistics, and social and behavioural research. The institute delivers TB research services spanning clinical research, diagnostics development, treatment protocol optimization, and epidemiological studies, and offers academic programs including PhD (with AcSIR), Internship/Dissertation, and capacity-building workshops for medical colleges and NTEP staff.

ICMR-NIRT's technical infrastructure includes BSL-3 and ABSL-3 composite facilities with a biorepository at Tiruvallur, advanced flow cytometry (BD FACS Symphony A5 SE), LCMSMS, and molecular diagnostics including tNGS for drug-resistant TB. It operates a Technical Resource Centre for evidence-based guidelines, an HTAIn Regional Resource Hub for health economics, and the Model Rural Health Research Unit (MRHRU) in Madurai, with additional units in Vellore and Tiruvallur. Service offerings include REDCap-based data capture, the IN-CXR chest X-ray analysis tool, systematic reviews, and stakeholder consultation platforms. The institute is funded entirely through government budgetary allocations, with no commercial pricing; outputs are delivered to NTEP, state health departments, medical colleges, and WHO/SEAR partners free at the point of use. Strategic partnerships span McGill University, BD Biosciences, Thermo Fisher, The UNION, Boditech Med, Anderson Diagnostics, and AYUSH institutions such as the National Institute of Siddha and CCRS.

Short descriptiontext

ICMR-NIRT is a Government of India research institute under ICMR, headquartered in Chennai, that serves as the National Reference Laboratory for Tuberculosis, conducting clinical, diagnostic, immunological, and epidemiological TB research while training medical staff and shaping national TB policy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersChennai, India
HQ citystring
Chennai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
tuberculosis research, infectious disease diagnostics, clinical trials research, epidemiological surveillance, public health research
Industry5 codes
1Tuberculosis & Mycobacterial Diseases
CodeHLAKAGAHPrimaryYes
2National Public Health Reference Laboratories
CodeHLAJAIAAPrimaryNo
3Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs)
CodeHLAJAOAEPrimaryNo
4General Infectious Disease
CodeHLAKAGAAPrimaryNo
5Molecular & Genetic Testing (PCR/NGS/qPCR)
CodeHLAGADAFPrimaryNo
NAICS code3 codes
  • Medical and Diagnostic Laboratories62151
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services541690
SIC code4 codes
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Tuberculosis Research and Diagnostics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Government Research Funding
TypeLicensing Royalties
Description

As an Indian Council of Medical Research (ICMR) institute under the Government of India, NIRT operates entirely on government funding for tuberculosis research, public health initiatives, and capacity building programs.

nirt.res.in
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1TRC (Technical Resource Centre)
Description

Technical Resource Centre for evidence-based guidelines and systematic reviews

nirt.res.in
+3 more records
Core offering1 text field

NIRT is a government research institute under the Indian Council of Medical Research (ICMR) that conducts clinical, operational, and basic research on tuberculosis. It provides specialized TB diagnostic services, operates field research units for epidemiological studies, runs vaccine and drug clinical trials, and offers technical support and training to India's National TB Elimination Programme (NTEP) and medical institutions.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

ICMR National Institute for Research in Tuberculosis (NIRT) is a premier government research institute under the Indian Council of Medical Research (ICMR), Government of India. The institute functions as a National Reference Laboratory for Tuberculosis and conducts comprehensive TB research across 16 specialized divisions including Bacteriology, Biochemistry, Clinical Pharmacology, Clinical Research, Epidemiology, Immunology, Virology & Biotechnology, and Health Economics. The institute offers academic programs (PhD and Internship/Dissertation), operates Technical Resource Centre for evidence synthesis, maintains a Regional Resource Hub for Health Technology Assessment (HTAIn), and operates the Model Rural Health Research Unit (MRHRU) in Madurai. NIRT provides research services, training programs, and tools such as IN-CXR chest X-ray analysis and REDCap data management platform to advance tuberculosis elimination efforts in India.

Product and service1 record
1TB Clinical and Operational Research
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Signing of MoU between ICMR-NIRT and CCRS for promotion of collaborative research for TB elimination through Siddha integration, exploring integrated solutions leveraging Siddha formulations as adjuncts to conventional TB treatment.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-15
Description

ICMR-NIRT collaborated with McGill University to conduct a five-day Advanced TB Diagnostics capacity-building workshop from December 15-19, 2025. The workshop brought together participants from National TB Programmes, public sector institutions, medical colleges, laboratories, industry partners and TB programmes from India and South-East Asian Region countries.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-10-14
Description

ICMR-NIRT collaborated with Madras Christian College and Agaramthen Panchayat Office to organize a Tuberculosis Awareness Programme for 45 sanitation workers on October 14, 2025.

Strategic tierMajorTypeTechnology or IntegrationAnnounced on2025-09-02
Description

Department of Immunology at ICMR-NIRT collaborated with BD Biosciences for a 2-day flow cytometry workshop titled 'Beyond the Horizon' on September 2-3, 2025. BD provided expertise on spectral plus imaging flow cytometry and high parameter multi-color flow cytometry panel design, with hands-on sessions on the BD FACS Symphony A5 SE Cell Analyzer.

5Directorate of Public Health & Preventive Medicine, Government of Tamil Nadu
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-21
Description

Collaboration with Directorate of Public Health & Preventive Medicine and NHM-TN for HTA sensitization program. Event attended by Principal Secretary to Government of Tamil Nadu and Joint Secretary of Department of Health Research, Govt. of India.

nirt.res.in
Strategic tierMajorTypeTechnology or IntegrationAnnounced on2025-04-25
Description

ICMR-NIRT celebrated International DNA Day on April 25, 2025 in collaboration with Thermo Fisher Scientific. The event featured product exhibition with 'Touch and Feel' experience and technical presentations on cutting-edge technologies in cell imaging and protein & cell analysis.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-04-23
Description

Department of Biochemistry of ICMR-NIRT collaborated with Anderson Diagnostics and Labs for World Laboratory Day 2025 symposium titled 'Labs Save Lives' at Robert Koch Auditorium, emphasizing crucial role of laboratory professionals in diagnosis and public health.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-03-28
Description

ICMR-NIRT collaborated with National Institute of Siddha for World TB Day 2025 awareness event at Agathiyar Arangam, Tambaram. Prof. Dr. G. Senthilvel, Director highlighted role of Siddha nutrition in TB prevention.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-02-28
Description

ICMR-NIRT collaborated with Women's Collective Forum to organize the 2nd Regional TB Stakeholders Consultation meeting on February 28, 2025 at New Delhi. Delegates from Central Tuberculosis Division, WHO, ICMR, NGOs, private and government pulmonologists, The UNION, STOP TB partnership and World Bank participated.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-08
Description

Technical Resource Centre of ICMR-NIRT jointly organized a two-day workshop on Systematic Reviews of Diagnostic Accuracy and GRADE with DHR. Dr Rajiv Bahl, Director General of ICMR & Secretary of DHR, addressed participants and highlighted importance of capacity building.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-25
Description

Model Rural Health Research Unit (MRHRU) Madurai launched at MEU Hall, Madurai Medical College during first LRAC meeting. Director of Public Health, Tamil Nadu, delivered inaugural address with collaboration between ICMR-NIRT and Madurai Medical College for rural health research.

12The UNION (International Union Against Tuberculosis and Lung Disease)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-22
Description

Three-day Training of Trainers workshop on 'Comprehensive strategy for Retention In TB Infection Cascade of Care' (CRITIC ToT) jointly organized by ICMR, ICMR-NIRT & The UNION under South East Asia Regional RESEARCH Platform. Participants from Kerala and 4 SEAR countries (Sri Lanka, Bhutan, Indonesia, Nepal) attended.

nirt.res.in
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1FIND (Foundation for Innovative New Diagnostics)
TypeDirect peer
Description

Global non-profit driving development and delivery of diagnostics for poverty-related diseases, especially TB (including tNGS for drug-resistant TB which NIRT also uses). Operates adjacent to NIRT in TB diagnostic research and validation.

2ICMR National Institute of Epidemiology (NIE)
TypeDirect peer
Description

Sister ICMR institute in Chennai specializing in epidemiology and field-based research. Directly comparable as a peer ICMR research institute with overlapping mandate in TB epidemiology and population health research.

TypeEmerging player
Description

Global multi-stakeholder partnership hosted by UNOPS accelerating TB elimination. NIRT has directly partnered with Stop TB Partnership on regional stakeholder consultations, making it a comparable participant in TB elimination advocacy.

4Translational Health Science and Technology Institute (THSTI)
TypeDirect peer
Description

Indian government autonomous institute under DBT focused on translational research including infectious diseases and vaccine/diagnostic development. Comparable as an India-based translational health research institute with BSL facilities and clinical research programs.

5International Union Against Tuberculosis and Lung Disease (The UNION)
TypeDirect peer
Description

International scientific organization focused on TB and lung disease, with which NIRT directly collaborates on training (CRITIC ToT) and South-East Asia regional research platforms. Operates in the same TB research, capacity-building, and policy advocacy space.

TypeBroad incumbent
Description

U.S. government research institute under NIH focused on infectious diseases including TB. Directly comparable as a publicly funded infectious disease research powerhouse with high-containment labs and global health policy influence.

TypeBroad incumbent
Description

Premier Indian government medical research and teaching institution with extensive infectious disease, immunology, and clinical trial capacity. A direct peer as another ICMR-aligned government medical research powerhouse with national scope.

TypeDirect peer
Description

Indian tertiary care and research institution with strong infectious disease and clinical trial capabilities; comparable as a medical research and academic medical center operating in India, often partnering with ICMR on TB and infectious disease research.

TypeRegional player
Description

South African TB research center with strong translational research and clinical trial capabilities for TB/HIV. Comparable as an academic TB research center operating in a high-burden country, though focused on a different geography (Africa vs. India).

TypeDirect peer
Description

Bangalore-based research institute with strong infectious disease, epidemiology, and clinical trial capacity in India. Comparable as an India-focused clinical and public health research organization working on TB, HIV, and nutrition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

National Institute for Research in Tuberculosis

Tuberculosis Research and Diagnosticsnirt.res.in

ICMR-NIRT is a Government of India research institute under ICMR, headquartered in Chennai, that serves as the National Reference Laboratory for Tuberculosis, conducting clinical, diagnostic, immunological, and epidemiological TB research while training medical staff and shaping national TB policy.

What National Institute for Research in Tuberculosis does

The National Institute for Research in Tuberculosis (ICMR-NIRT) is a Government of India research institute established in 1956 and headquartered in Chetpet, Chennai, under the Indian Council of Medical Research (ICMR) within the Ministry of Health and Family Welfare. It functions as the National Reference Laboratory for Tuberculosis and operates 16 specialized divisions covering bacteriology, biochemistry, clinical pharmacology, clinical research, epidemiology, health economics, immunology, virology and biotechnology, statistics, and social and behavioural research. The institute delivers TB research services spanning clinical research, diagnostics development, treatment protocol optimization, and epidemiological studies, and offers academic programs including PhD (with AcSIR), Internship/Dissertation, and capacity-building workshops for medical colleges and NTEP staff.

ICMR-NIRT's technical infrastructure includes BSL-3 and ABSL-3 composite facilities with a biorepository at Tiruvallur, advanced flow cytometry (BD FACS Symphony A5 SE), LCMSMS, and molecular diagnostics including tNGS for drug-resistant TB. It operates a Technical Resource Centre for evidence-based guidelines, an HTAIn Regional Resource Hub for health economics, and the Model Rural Health Research Unit (MRHRU) in Madurai, with additional units in Vellore and Tiruvallur. Service offerings include REDCap-based data capture, the IN-CXR chest X-ray analysis tool, systematic reviews, and stakeholder consultation platforms. The institute is funded entirely through government budgetary allocations, with no commercial pricing; outputs are delivered to NTEP, state health departments, medical colleges, and WHO/SEAR partners free at the point of use. Strategic partnerships span McGill University, BD Biosciences, Thermo Fisher, The UNION, Boditech Med, Anderson Diagnostics, and AYUSH institutions such as the National Institute of Siddha and CCRS.

National Institute for Research in Tuberculosis firmographics

Firmographics
Name
National Institute for Research in Tuberculosis
Legal name
ICMR National Institute for Research in Tuberculosis
Website
https://nirt.res.in
Company type
Private
Founded year
1956
Operating status
Operating
Headcount range
101–250 employees
Short description
ICMR-NIRT is a Government of India research institute under ICMR, headquartered in Chennai, that serves as the National Reference Laboratory for Tuberculosis, conducting clinical, diagnostic, immunological, and epidemiological TB research while training medical staff and shaping national TB policy.
Ownership category
akta.pro rank

National Institute for Research in Tuberculosis industry classification

Industry
Product category
Tuberculosis Research and Diagnostics
NAICS
Medical and Diagnostic Laboratories (62151), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690)
SIC
Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Tuberculosis & Mycobacterial Diseases (HLAKAGAH)
akta.pro secondary industries
National Public Health Reference Laboratories (HLAJAIAA), Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs) (HLAJAOAE), General Infectious Disease (HLAKAGAA), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

  • Tuberculosis research
  • Infectious disease diagnostics
  • Clinical trials research
  • Epidemiological surveillance
  • Public health research

Where National Institute for Research in Tuberculosis is headquartered

Location

Headquarters

HQ city
Chennai
HQ country
India
HQ region
Asia

Offices4 records

Markets served

National Institute for Research in Tuberculosis business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

  1. Government Research Funding: As an Indian Council of Medical Research (ICMR) institute under the Government of India, NIRT operates entirely on government funding for tuberculosis research, public health initiatives, and capacity building programs.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

National Institute for Research in Tuberculosis product offering

Product offering

Core offering

NIRT is a government research institute under the Indian Council of Medical Research (ICMR) that conducts clinical, operational, and basic research on tuberculosis. It provides specialized TB diagnostic services, operates field research units for epidemiological studies, runs vaccine and drug clinical trials, and offers technical support and training to India's National TB Elimination Programme (NTEP) and medical institutions.

Product overview

ICMR National Institute for Research in Tuberculosis (NIRT) is a premier government research institute under the Indian Council of Medical Research (ICMR), Government of India. The institute functions as a National Reference Laboratory for Tuberculosis and conducts comprehensive TB research across 16 specialized divisions including Bacteriology, Biochemistry, Clinical Pharmacology, Clinical Research, Epidemiology, Immunology, Virology & Biotechnology, and Health Economics. The institute offers academic programs (PhD and Internship/Dissertation), operates Technical Resource Centre for evidence synthesis, maintains a Regional Resource Hub for Health Technology Assessment (HTAIn), and operates the Model Rural Health Research Unit (MRHRU) in Madurai. NIRT provides research services, training programs, and tools such as IN-CXR chest X-ray analysis and REDCap data management platform to advance tuberculosis elimination efforts in India.

Differentiator

Problem solved

Functional benefit

Brands

  • TRC (Technical Resource Centre): Technical Resource Centre for evidence-based guidelines and systematic reviews
  • HTAIn Regional Resource Hub
  • MRHRU Madurai
  • Wings of Support

Products and services

  • TB Clinical and Operational Research

Companies that use National Institute for Research in Tuberculosis

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles3 records

National Institute for Research in Tuberculosis technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

National Institute for Research in Tuberculosis partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core, minor and major.

  • Central Council for Research in Siddha (CCRS)coreStrategic or Co-development Partner · 1 January 2026Signing of MoU between ICMR-NIRT and CCRS for promotion of collaborative research for TB elimination through Siddha integration, exploring integrated solutions leveraging Siddha formulations as adjuncts to conventional TB treatment.
  • McGill University, CanadacoreStrategic or Co-development Partner · 15 December 2025ICMR-NIRT collaborated with McGill University to conduct a five-day Advanced TB Diagnostics capacity-building workshop from December 15-19, 2025. The workshop brought together participants from National TB Programmes, public sector institutions, medical colleges, laboratories, industry partners and TB programmes from India and South-East Asian Region countries.
  • Madras Christian College (MCC)minorStrategic or Co-development Partner · 14 October 2025ICMR-NIRT collaborated with Madras Christian College and Agaramthen Panchayat Office to organize a Tuberculosis Awareness Programme for 45 sanitation workers on October 14, 2025.
  • BD BiosciencesmajorTechnology or Integration · 2 September 2025Department of Immunology at ICMR-NIRT collaborated with BD Biosciences for a 2-day flow cytometry workshop titled 'Beyond the Horizon' on September 2-3, 2025. BD provided expertise on spectral plus imaging flow cytometry and high parameter multi-color flow cytometry panel design, with hands-on sessions on the BD FACS Symphony A5 SE Cell Analyzer.
  • Directorate of Public Health & Preventive Medicine, Government of Tamil NaducoreStrategic or Co-development Partner · 21 May 2025Collaboration with Directorate of Public Health & Preventive Medicine and NHM-TN for HTA sensitization program. Event attended by Principal Secretary to Government of Tamil Nadu and Joint Secretary of Department of Health Research, Govt. of India.
  • Thermo Fisher ScientificmajorTechnology or Integration · 25 April 2025ICMR-NIRT celebrated International DNA Day on April 25, 2025 in collaboration with Thermo Fisher Scientific. The event featured product exhibition with 'Touch and Feel' experience and technical presentations on cutting-edge technologies in cell imaging and protein & cell analysis.
  • Anderson Diagnostics and LabsminorStrategic or Co-development Partner · 23 April 2025Department of Biochemistry of ICMR-NIRT collaborated with Anderson Diagnostics and Labs for World Laboratory Day 2025 symposium titled 'Labs Save Lives' at Robert Koch Auditorium, emphasizing crucial role of laboratory professionals in diagnosis and public health.
  • National Institute of SiddhamajorStrategic or Co-development Partner · 28 March 2025ICMR-NIRT collaborated with National Institute of Siddha for World TB Day 2025 awareness event at Agathiyar Arangam, Tambaram. Prof. Dr. G. Senthilvel, Director highlighted role of Siddha nutrition in TB prevention.
  • Women's Collective ForummajorStrategic or Co-development Partner · 28 February 2025ICMR-NIRT collaborated with Women's Collective Forum to organize the 2nd Regional TB Stakeholders Consultation meeting on February 28, 2025 at New Delhi. Delegates from Central Tuberculosis Division, WHO, ICMR, NGOs, private and government pulmonologists, The UNION, STOP TB partnership and World Bank participated.
  • Department of Health Research, Ministry of Health and Family WelfarecoreStrategic or Co-development Partner · 8 January 2025Technical Resource Centre of ICMR-NIRT jointly organized a two-day workshop on Systematic Reviews of Diagnostic Accuracy and GRADE with DHR. Dr Rajiv Bahl, Director General of ICMR & Secretary of DHR, addressed participants and highlighted importance of capacity building.
  • Madurai Medical CollegecoreStrategic or Co-development Partner · 25 October 2024Model Rural Health Research Unit (MRHRU) Madurai launched at MEU Hall, Madurai Medical College during first LRAC meeting. Director of Public Health, Tamil Nadu, delivered inaugural address with collaboration between ICMR-NIRT and Madurai Medical College for rural health research.
  • The UNION (International Union Against Tuberculosis and Lung Disease)coreStrategic or Co-development Partner · 22 July 2024Three-day Training of Trainers workshop on 'Comprehensive strategy for Retention In TB Infection Cascade of Care' (CRITIC ToT) jointly organized by ICMR, ICMR-NIRT & The UNION under South East Asia Regional RESEARCH Platform. Participants from Kerala and 4 SEAR countries (Sri Lanka, Bhutan, Indonesia, Nepal) attended.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

National Institute for Research in Tuberculosis competitors and assessment

Company assessment

Direct peers

  • FIND (Foundation for Innovative New Diagnostics): Global non-profit driving development and delivery of diagnostics for poverty-related diseases, especially TB (including tNGS for drug-resistant TB which NIRT also uses). Operates adjacent to NIRT in TB diagnostic research and validation.
  • ICMR National Institute of Epidemiology (NIE): Sister ICMR institute in Chennai specializing in epidemiology and field-based research. Directly comparable as a peer ICMR research institute with overlapping mandate in TB epidemiology and population health research.
  • Translational Health Science and Technology Institute (THSTI): Indian government autonomous institute under DBT focused on translational research including infectious diseases and vaccine/diagnostic development. Comparable as an India-based translational health research institute with BSL facilities and clinical research programs.
  • International Union Against Tuberculosis and Lung Disease (The UNION): International scientific organization focused on TB and lung disease, with which NIRT directly collaborates on training (CRITIC ToT) and South-East Asia regional research platforms. Operates in the same TB research, capacity-building, and policy advocacy space.
  • Christian Medical College (CMC) Vellore: Indian tertiary care and research institution with strong infectious disease and clinical trial capabilities; comparable as a medical research and academic medical center operating in India, often partnering with ICMR on TB and infectious disease research.
  • St. John's Research Institute: Bangalore-based research institute with strong infectious disease, epidemiology, and clinical trial capacity in India. Comparable as an India-focused clinical and public health research organization working on TB, HIV, and nutrition.

Emerging players

  • Stop TB Partnership: Global multi-stakeholder partnership hosted by UNOPS accelerating TB elimination. NIRT has directly partnered with Stop TB Partnership on regional stakeholder consultations, making it a comparable participant in TB elimination advocacy.

Broad incumbents

  • National Institute of Allergy and Infectious Diseases (NIAID): U.S. government research institute under NIH focused on infectious diseases including TB. Directly comparable as a publicly funded infectious disease research powerhouse with high-containment labs and global health policy influence.
  • All India Institute of Medical Sciences (AIIMS): Premier Indian government medical research and teaching institution with extensive infectious disease, immunology, and clinical trial capacity. A direct peer as another ICMR-aligned government medical research powerhouse with national scope.

Regional players

  • Desmond Tutu TB Centre, Stellenbosch University: South African TB research center with strong translational research and clinical trial capabilities for TB/HIV. Comparable as an academic TB research center operating in a high-burden country, though focused on a different geography (Africa vs. India).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

National Institute for Research in Tuberculosis social profiles

Digital presence

National Institute for Research in Tuberculosis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

National Institute for Research in Tuberculosis leadership team

Management profile

Number of profiles

Profiles1 record

National Institute for Research in Tuberculosis subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

National Institute for Research in Tuberculosis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

National Institute for Research in Tuberculosis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Institute for Research in Tuberculosis

What does National Institute for Research in Tuberculosis do?

NIRT is a government research institute under the Indian Council of Medical Research (ICMR) that conducts clinical, operational, and basic research on tuberculosis. It provides specialized TB diagnostic services, operates field research units for epidemiological studies, runs vaccine and drug clinical trials, and offers technical support and training to India's National TB Elimination Programme (NTEP) and medical institutions.

Is National Institute for Research in Tuberculosis a public or private company?

National Institute for Research in Tuberculosis is a private company. It is classified as state government owned and is currently operating.

When was National Institute for Research in Tuberculosis founded?

National Institute for Research in Tuberculosis was founded in 1956. It employs 101 to 250 people.

Where is National Institute for Research in Tuberculosis based?

National Institute for Research in Tuberculosis is headquartered in Chennai, India, in the Asia region.

How does National Institute for Research in Tuberculosis make money?

One revenue line is on record: government Research Funding.

Who are National Institute for Research in Tuberculosis's main competitors?

Direct peers on record are FIND (Foundation for Innovative New Diagnostics), ICMR National Institute of Epidemiology (NIE), Translational Health Science and Technology Institute (THSTI), International Union Against Tuberculosis and Lung Disease (The UNION), Christian Medical College (CMC) Vellore and St. John's Research Institute. Stop TB Partnership is listed as an emerging player. Broad incumbents are National Institute of Allergy and Infectious Diseases (NIAID) and All India Institute of Medical Sciences (AIIMS). Desmond Tutu TB Centre, Stellenbosch University is listed as a regional player.

Does National Institute for Research in Tuberculosis have an API?

No public API is recorded for National Institute for Research in Tuberculosis.

What industry is National Institute for Research in Tuberculosis in?

National Institute for Research in Tuberculosis's product category is Tuberculosis Research and Diagnostics. Its primary akta.pro industry code is HLAKAGAH, Tuberculosis & Mycobacterial Diseases, with a secondary code of HLAJAIAA, National Public Health Reference Laboratories. Its NAICS code is 62151 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Times of IndiaOverzealous immune response early in TB may signal risk of treatment failureScientists from ICMR National Institute for Tuberculosis Research found that patients mounting an unusually aggressive immune response to tuberculosis early in treatment may be less likely to respond well to standard drug therapy. The study, funded by the Department of Biotechnology and published in Frontiers in Immunology, tested 68 patients with poor treatment outcomes against 108 who completed treatment, identifying complement system proteins as an early warning signal for treatment failure. Researchers concluded that a simple blood test measuring complement components could help doctors identify high-risk patients early and adjust therapy before the disease worsens.Business StandardShorter six-month DR-TB treatment cheaper, more effective: ICMR studyAn ICMR study conducted by its National Institute for Research in Tuberculosis (NIRT) found that six-month all-oral treatment regimens (BPaL and BPaLM) for multidrug-resistant and rifampicin-resistant tuberculosis are more cost-effective and offer improved health outcomes compared to the longer 9-11 month and 18-20 month regimens currently used in India. The economic evaluation published in the Indian Journal of Medical Research revealed that BPaL saves ₹379 per quality-adjusted life year gained, while BPaLM adds only ₹37 per QALY gained compared to standard treatment. The study provides evidence to support programmatic adoption of these shorter regimens under the National TB Elimination Programme to accelerate India's tuberculosis elimination efforts.